p53 signaling in cancer progression and therapy

HE Marei, A Althani, N Afifi, A Hasan, T Caceci… - Cancer cell …, 2021 - Springer
The p53 protein is a transcription factor known as the" guardian of the genome" because of
its critical function in preserving genomic integrity. The TP53 gene is mutated in …

Regulating tumor suppressor genes: post-translational modifications

L Chen, S Liu, Y Tao - Signal transduction and targeted therapy, 2020 - nature.com
Tumor suppressor genes cooperate with each other in tumors. Three important tumor
suppressor proteins, retinoblastoma (Rb), p53, phosphatase, and tensin homolog deleted …

Cas9 activates the p53 pathway and selects for p53-inactivating mutations

OM Enache, V Rendo, M Abdusamad, D Lam… - Nature …, 2020 - nature.com
Cas9 is commonly introduced into cell lines to enable CRISPR–Cas9-mediated genome
editing. Here, we studied the genetic and transcriptional consequences of Cas9 expression …

Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy

B Song, P Yang, S Zhang - Cancer communications, 2024 - Wiley Online Library
Cancer is a leading cause of death worldwide. Targeted therapies aimed at key oncogenic
driver mutations in combination with chemotherapy and radiotherapy as well as …

TRIM family contribute to tumorigenesis, cancer development, and drug resistance

N Huang, X Sun, P Li, X Liu, X Zhang, Q Chen… - … Hematology & Oncology, 2022 - Springer
The tripartite-motif (TRIM) family represents one of the largest classes of putative single
protein RING-finger E3 ubiquitin ligases. TRIM family is involved in a variety of cellular …

The p53 tumor suppressor in the control of metabolism and ferroptosis

K Gnanapradeepan, S Basu, T Barnoud… - Frontiers in …, 2018 - frontiersin.org
The p53 tumor suppressor continues to be distinguished as the most frequently mutated
gene in human cancer. It is widely believed that the ability of p53 to induce senescence and …

Multifunctional barcoding with ClonMapper enables high-resolution study of clonal dynamics during tumor evolution and treatment

C Gutierrez, AM Al'Khafaji, E Brenner, KE Johnson… - Nature Cancer, 2021 - nature.com
Lineage-tracing methods have enabled characterization of clonal dynamics in complex
populations, but generally lack the ability to integrate genomic, epigenomic and …

It's getting complicated—a fresh look at p53-MDM2-ARF triangle in tumorigenesis and cancer therapy

CP Kung, JD Weber - Frontiers in cell and developmental biology, 2022 - frontiersin.org
Anti-tumorigenic mechanisms mediated by the tumor suppressor p53, upon oncogenic
stresses, are our bodies' greatest weapons to battle against cancer onset and development …

The role of the p53 tumor suppressor in metabolism and diabetes

CP Kung, ME Murphy - The Journal of endocrinology, 2016 - pmc.ncbi.nlm.nih.gov
In the context of tumor suppression, p53 is an undisputedly critical protein. Functioning
primarily as a transcription factor, p53 helps fend off the initiation and progression of tumors …

c-Myc inactivation of p53 through the pan-cancer lncRNA MILIP drives cancer pathogenesis

YC Feng, XY Liu, L Teng, Q Ji, Y Wu, JM Li… - Nature …, 2020 - nature.com
The functions of the proto-oncoprotein c-Myc and the tumor suppressor p53 in controlling
cell survival and proliferation are inextricably linked as “Yin and Yang” partners in normal …